Nigeria’s Swipha Achieves WHO Prequalification for Malaria Drug in Milestone for African Manufacturing
Nigerian pharmaceutical manufacturer Swipha has received prequalification from the World Health Organization (WHO) for their sulfadoxine-pyrimethamine (SP), a key medication used to prevent malaria in pregnant women. This marks a major achievement in Africa’s fight against malaria, particularly in Nigeria, which bears the highest malaria burden globally. The company underwent a rigorous process to submit…